Yichuan Xu

1.1k total citations · 1 hit paper
33 papers, 770 citations indexed

About

Yichuan Xu is a scholar working on Molecular Biology, Biomedical Engineering and Organic Chemistry. According to data from OpenAlex, Yichuan Xu has authored 33 papers receiving a total of 770 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Biomedical Engineering and 4 papers in Organic Chemistry. Recurrent topics in Yichuan Xu's work include Microfluidic and Capillary Electrophoresis Applications (7 papers), Innovative Microfluidic and Catalytic Techniques Innovation (4 papers) and Microfluidic and Bio-sensing Technologies (4 papers). Yichuan Xu is often cited by papers focused on Microfluidic and Capillary Electrophoresis Applications (7 papers), Innovative Microfluidic and Catalytic Techniques Innovation (4 papers) and Microfluidic and Bio-sensing Technologies (4 papers). Yichuan Xu collaborates with scholars based in China, United States and Israel. Yichuan Xu's co-authors include Zhe Shi, Hao Cheng, Chenghao Gao, Kan Yue, Xusheng Huang, Zhongqi Yao, Yu Shrike Zhang, Jian Wang, J. Thomas Brenna and Sean M. Ford and has published in prestigious journals such as Analytical Chemistry, Chemical Engineering Journal and Journal of Chromatography A.

In The Last Decade

Yichuan Xu

30 papers receiving 757 citations

Hit Papers

Sprayable hydrogel dressing accelerates wound healing wit... 2021 2026 2022 2024 2021 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yichuan Xu China 16 239 165 160 152 83 33 770
Dinesh Nyavanandi United States 19 368 1.5× 193 1.2× 304 1.9× 266 1.8× 50 0.6× 31 1.3k
Binglin Li China 17 270 1.1× 149 0.9× 301 1.9× 218 1.4× 87 1.0× 73 1.1k
Jun Gu China 19 229 1.0× 114 0.7× 182 1.1× 166 1.1× 41 0.5× 64 946
Zhirong Guo China 12 127 0.5× 107 0.6× 101 0.6× 121 0.8× 52 0.6× 30 566
Saahil Arora India 15 274 1.1× 52 0.3× 152 0.9× 343 2.3× 44 0.5× 47 1.1k
Zhaoyuan Guo China 14 285 1.2× 140 0.8× 135 0.8× 283 1.9× 72 0.9× 28 792
Jiayin Song China 17 313 1.3× 305 1.8× 180 1.1× 282 1.9× 85 1.0× 58 1.2k
Marius Rădulescu Romania 16 186 0.8× 54 0.3× 71 0.4× 200 1.3× 60 0.7× 39 589
Jiří Nečas Czechia 10 167 0.7× 41 0.2× 220 1.4× 201 1.3× 63 0.8× 38 1.0k
Qian Tang China 19 185 0.8× 73 0.4× 347 2.2× 137 0.9× 28 0.3× 52 942

Countries citing papers authored by Yichuan Xu

Since Specialization
Citations

This map shows the geographic impact of Yichuan Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yichuan Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yichuan Xu more than expected).

Fields of papers citing papers by Yichuan Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yichuan Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yichuan Xu. The network helps show where Yichuan Xu may publish in the future.

Co-authorship network of co-authors of Yichuan Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Yichuan Xu. A scholar is included among the top collaborators of Yichuan Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yichuan Xu. Yichuan Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Yichuan, et al.. (2025). Multifractal Spectrum Analysis for Assessing Pulmonary Nodule Malignancy. Journal of Visualized Experiments.
3.
4.
Li, Jianhao, Liyun Yang, Huanzhen Xie, et al.. (2023). Research on impact toughness and crack propagation of basalt fiber reinforced concrete under SHPB splitting test. Journal of Building Engineering. 77. 107445–107445. 34 indexed citations
5.
Dong, Zhaoxia, Zhigang Fang, Yichuan Xu, et al.. (2023). E2F2 modulates cell adhesion through the transcriptional regulation of PECAM1 in multiple myeloma. British Journal of Haematology. 202(4). 840–855. 8 indexed citations
8.
Cheng, Hao, Haibing Liu, Zhe Shi, et al.. (2022). Long-term antibacterial and biofilm dispersion activity of an injectable in situ crosslinked co-delivery hydrogel/microgel for treatment of implant infection. Chemical Engineering Journal. 433. 134451–134451. 36 indexed citations
9.
Xu, Xuying, et al.. (2022). The Haoqin-Huaban formula alleviates UVB-induced skin damage through HOXA11-AS-mediated stabilization of EZH2.. PubMed. 14(4). 2212–2230. 2 indexed citations
11.
Cheng, Hao, Zhe Shi, Kan Yue, et al.. (2021). Sprayable hydrogel dressing accelerates wound healing with combined reactive oxygen species-scavenging and antibacterial abilities. Acta Biomaterialia. 124. 219–232. 287 indexed citations breakdown →
12.
Wang, Jian, et al.. (2021). Incidence, Outcomes and Risk Factors of Heparin-Induced Thrombocytopenia After Total Joint Arthroplasty: A National Inpatient Sample Database Study. Clinical and Applied Thrombosis/Hemostasis. 27. 2975224442–2975224442. 3 indexed citations
13.
Yang, Qinfeng, Jian Wang, Xusheng Huang, Yichuan Xu, & Yang Zhang. (2020). Incidence and risk factors associated with postoperative delirium following primary elective total hip arthroplasty: a retrospective nationwide inpatient sample database study. BMC Psychiatry. 20(1). 343–343. 34 indexed citations
14.
Yang, Qinfeng, Jian Wang, Yichuan Xu, et al.. (2020). Incidence and risk factors of in-hospital prosthesis-related complications following total hip arthroplasty: a retrospective Nationwide Inpatient Sample database study. International Orthopaedics. 44(11). 2243–2252. 19 indexed citations
15.
Fan, Ruifang, Ying Lu, Zhigang Fang, et al.. (2017). PIM-1 kinase inhibitor SMI-4a exerts antitumor effects in chronic myeloid leukemia cells by enhancing the activity of glycogen synthase kinase 3β. Molecular Medicine Reports. 16(4). 4603–4612. 17 indexed citations
16.
Lu, Ying, Xiangfu Liu, Ruifang Fan, et al.. (2016). Celecoxib exerts antitumor effects in HL-60 acute leukemia cells and inhibits autophagy by affecting lysosome function. Biomedicine & Pharmacotherapy. 84. 1551–1557. 23 indexed citations
17.
Fan, Ruifang, Xiaoyan Guo, Ying Lu, et al.. (2016). Zoledronic acid overcomes adriamycin resistance in acute myeloid leukemia cells by promoting apoptosis. Molecular Medicine Reports. 14(6). 5660–5666. 3 indexed citations
18.
Xu, Yichuan, et al.. (2004). Direct from Polyacrylamide Gel Infrared Laser Desorption/Ionization. Analytical Chemistry. 76(4). 1078–1082. 16 indexed citations
19.
Xu, Yichuan, Richard C. Bruch, & Steven A. Soper. (2000). Microcapillary Reactors Using Solid-Phase DNA Sequencing for Direct Sample Introduction into Slab Gels. BioTechniques. 28(5). 904–912. 1 indexed citations
20.
Soper, Steven A., Sean M. Ford, Yichuan Xu, et al.. (1999). Nanoliter-scale sample preparation methods directly coupled to polymethylmethacrylate-based microchips and gel-filled capillaries for the analysis of oligonucleotides. Journal of Chromatography A. 853(1-2). 107–120. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026